科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06990 科伦博泰生物-B

休市中 02-06 16:08:04

423.200

+3.000

+0.71%

最高439.600	最低410.800	成交量35.40万
今开412.000	昨收420.200	日振幅6.85%
总市值986.84亿	流通市值688.84亿	总股本2.33亿
成交额1.51亿	换手率0.22%	流通股本1.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科伦博泰生物-B","latestPrice":423.2,"timestamp":1770365284006,"preClose":420.2,"halted":0,"volume":354009,"delay":0,"changeRate":0.007139457401237506,"floatShares":162769979,"shares":233185969,"eps":-1.203559,"marketStatus":"休市中","change":3,"latestTime":"02-06 16:08:04","open":412,"high":439.6,"low":410.8,"amount":151490806,"amplitude":0.068539,"askPrice":423.2,"askSize":1200,"bidPrice":421,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-3.508831,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":420.2,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":0.7264703466449586,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06990","defaultTab":"news","newsList":[{"id":"1100448776","title":"科伦博泰生物-B宣布萨坦珠单抗（Sac-TMT）获NMPA批准用于HR+/HER2-乳腺癌，为第四项适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1100448776","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100448776?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:04","pubTimestamp":1770368678,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B宣布，其创新药物萨坦珠单抗已获得国家药品监督管理局批准，用于治疗HR阳性、HER2阴性乳腺癌患者。这是该药物在中国获批的第四项适应症，标志着其在肿瘤治疗领域的应用进一步扩展。此次获批基于临床试验数据，显示萨坦珠单抗在HR+/HER2-乳腺癌患者中表现出显著的疗效和可控的安全性。科伦博泰生物-B持续致力于创新药物的研发与商业化，此次新适应症的获批将有望提升萨坦珠单抗的市场潜力，并为公司未来业绩增长注入动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2609639435","title":"科伦博泰生物-B(06990)：核心产品TROP2ADC芦康沙妥珠单抗(sac-TMT)获国家药品监督管理局批准第四项适应症上市，用于治疗2L+HR+/HER2-乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2609639435","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609639435?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:36","pubTimestamp":1770366971,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B 发布公告，近日，本公司靶向人滋养细胞表面抗原2的抗体偶联药物芦康沙妥珠单抗(佳泰莱)的一项新增适应症上市申请已获中国国家药品监督管理局批准，用于治疗既往接受过内分泌治疗且在晚期疾病阶段接受过至少一线化疗的不可切除或转移性的激素受体阳性(HR+)且人类表皮生长因子受体2阴性乳腺癌成人患者。此次获批的至少经一线化疗治疗HR+/HER2-BC是芦康沙妥珠单抗在中国上市的第四项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0196878994.USD","HR","BK4203","06990","BK1161","BK4225"],"gpt_icon":0},{"id":"1128888972","title":"科伦博泰生物-B：Trop2 ADC药物Sacituzumab Tirumotecan获NMPA批准上市，适应症扩展至第四项","url":"https://stock-news.laohu8.com/highlight/detail?id=1128888972","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128888972?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:35","pubTimestamp":1770366912,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B宣布，其靶向Trop2的抗体偶联药物（ADC）Sacituzumab Tirumotecan已获得国家药品监督管理局（NMPA）批准上市。这是该药物获批的第四项适应症，标志着其在临床应用范围的进一步扩大。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"1109931140","title":"四川科伦博泰生物医药（06990）更新2026年1月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1109931140","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109931140?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:43","pubTimestamp":1770194587,"startTime":"0","endTime":"0","summary":"四川科伦博泰生物医药股份有限公司于2026年2月4日发布2026年1月股份变动月报表，报告期为2026年1月1日至1月31日。公告显示，公司整体股本结构保持稳定，未见新增发行或购回动作。根据月报表，公司截至2026年1月31日的注册股本总额为人民币233,185,969元，具体包括：H股162,769,979股，内资股65,773,800股，非上市外资股4,642,190股。上述各类已发行股份数量均与上月底相同，库存股份数目为零。本次月报表由联席公司秘书周泽剑签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"2608352283","title":"每日卖空追踪 | 科伦博泰生物-B 02月04日卖空量成交2.89万股，卖空比例为5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608352283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608352283?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193838,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月04日，涨5.28%，卖空量成交2.89万股，较上一交易日减少62.32%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163832a47b1127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163832a47b1127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2608635243","title":"科伦博泰生物-B02月04日获主力加仓196.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608635243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608635243?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192943,"startTime":"0","endTime":"0","summary":"02月04日, 科伦博泰生物-B股价涨5.28%，报收422.80元，成交金额2.2亿元，换手率0.33%，振幅8.32%，量比1.07。科伦博泰生物-B今日主力资金净流入196.7万元，连续6日净流入，上一交易日主力净流入264.8万元。近一年数据显示，该股主力连续6日净流入后，次日上涨概率为71.43%，平均涨幅为2.98%。该股近5个交易日下跌1.27%，主力资金累计净流入2117.8万元；近20日主力资金累计净流出1514.6万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161932a6d1f1a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161932a6d1f1a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2608829980","title":"科伦博泰生物-B02月03日获主力加仓264.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608829980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608829980?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:15","pubTimestamp":1770106539,"startTime":"0","endTime":"0","summary":"02月03日, 科伦博泰生物-B股价涨0.10%，报收401.60元，成交金额1.7亿元，换手率0.26%，振幅3.59%，量比0.88。科伦博泰生物-B今日主力资金净流入264.8万元，连续5日净流入，上一交易日主力净流入144.8万元。该股近5个交易日下跌1.76%，主力资金累计净流入3011.4万元；近20日主力资金累计净流出4612.4万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161908a476af20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161908a476af20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2608104688","title":"每日卖空追踪 | 科伦博泰生物-B 02月02日卖空量成交4.45万股，卖空比例为8.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608104688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608104688?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021038,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月02日，跌3.42%，卖空量成交4.45万股，较上一交易日减少76.28%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163833a6c987ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163833a6c987ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2608450810","title":"百济神州 ≈ 信达生物+科伦博泰+康方生物 ？","url":"https://stock-news.laohu8.com/highlight/detail?id=2608450810","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608450810?lang=zh_cn&edition=full","pubTime":"2026-02-02 11:29","pubTimestamp":1770002959,"startTime":"0","endTime":"0","summary":"截止到2026年2月2日午间市值数据显示：百济神州以约3070亿港元的市值，几乎等同于信达生物、科伦博泰生物与康方生物三者的总和。2025年第三季度，百济神州净利润达1.25亿美元，而去年同期为亏损1.21亿美元。信达生物、科伦博泰和康方生物则仍处于高增长、高投入阶段，其估值包含了风险溢价和未来成长潜力。对于信达生物、科伦博泰和康方生物而言，未来18-24个月是关键的验证期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BPRC5H50.USD","LU0417516902.SGD","01801","LU0455707207.USD","LU1794554557.SGD","LU1719994722.HKD","LU0348827113.USD","BK1161","LU0348784397.USD","LU0417516571.SGD","LU0634319403.HKD","BK1589","LU1303224171.USD","LU0348767384.USD","LU2097828474.EUR","LU2399975544.HKD","LU0348735423.USD","09926","HK0000165453.HKD","LU0196878994.USD","06990","LU0348783233.USD","LU0348766576.USD","06160","LU2488822045.USD","LU2476274720.SGD","BK1588","BK1500","LU0561508036.HKD","BK1574","IE00B5MMRT66.SGD","LU1251922891.USD","LU0417516738.SGD","LU0540923850.HKD","LU1961090484.USD","LU2328871848.SGD","LU1770034418.SGD","LU0502904849.HKD","LU1969619763.USD","LU2097828557.USD","LU0588546209.SGD","LU2097828631.EUR","LU2242644610.SGD","LU2778985437.USD","IE00B543WZ88.USD","LU2097828714.EUR","LU2097828805.USD","LU1720050803.USD","LU0348825331.USD","BK1583"],"gpt_icon":0},{"id":"2607075748","title":"每日卖空追踪 | 科伦博泰生物-B 01月30日卖空量成交3.57万股，卖空比例为8.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607075748","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607075748?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:30","pubTimestamp":1769761839,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月30日，涨0.29%，卖空量成交3.57万股，较上一交易日减少50.42%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164154a46857a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164154a46857a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2607757160","title":"科伦博泰生物-B01月30日获主力加仓1449.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607757160","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607757160?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:15","pubTimestamp":1769760942,"startTime":"0","endTime":"0","summary":"01月30日, 科伦博泰生物-B股价涨0.29%，报收415.40元，成交金额2.1亿元，换手率0.31%，振幅5.75%，量比0.93。科伦博泰生物-B今日主力资金净流入1449.9万元，连续3日净流入，上一交易日主力净流入61.6万元。该股近5个交易日下跌2.42%，主力资金累计净流出1096.6万元；近20日主力资金累计净流出7389.6万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162050a6bf361f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162050a6bf361f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2607674464","title":"每日卖空追踪 | 科伦博泰生物-B 01月28日卖空量成交4.23万股，卖空比例为7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607674464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607674464?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:30","pubTimestamp":1769589038,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月28日，涨3.61%，卖空量成交4.23万股，较上一交易日减少52.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128165056a45f8f4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128165056a45f8f4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2607446217","title":"科伦博泰生物-B01月28日主力净流入1090.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2607446217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607446217?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588128,"startTime":"0","endTime":"0","summary":"01月28日, 科伦博泰生物-B股价涨3.61%，报收425.00元，成交金额2.4亿元，换手率0.35%，振幅4.78%，量比0.92。科伦博泰生物-B今日主力资金净流入1090.3万元，上一交易日主力净流出359.7万元。该股近5个交易日上涨1.54%，主力资金累计净流出5286.4万元；近20日主力资金累计净流出8617.7万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161835a6b668ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161835a6b668ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2607744620","title":"科伦博泰生物-B盘中异动 大幅拉升3.02%报422.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607744620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607744620?lang=zh_cn&edition=full","pubTime":"2026-01-28 10:18","pubTimestamp":1769566686,"startTime":"0","endTime":"0","summary":"2026年01月28日早盘10时18分，科伦博泰生物-B股票出现异动，股价急速上涨3.02%。截至发稿，该股报422.600港元/股，成交量6.427万股，换手率0.04%，振幅3.66%。资金方面，该股资金流入1242万港元，流出1163.72万港元。科伦博泰生物-B股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，复宏汉霖、创胜集团-B、科伦博泰生物-B涨幅较大，振幅较大的相关个股有旺山旺水-B、维亚生物、复宏汉霖，振幅分别为9.73%、7.60%、7.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128101806953ea51b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128101806953ea51b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2606212269","title":"每日卖空追踪 | 科伦博泰生物-B 01月26日卖空量成交5.78万股，卖空比例为8.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606212269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606212269?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416239,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月26日，跌4.05%，卖空量成交5.78万股，较上一交易日减少44.26%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164318a6ad7aae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164318a6ad7aae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2606296721","title":"1月以来，国内外多家药企宣布延长 /深化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2606296721","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606296721?lang=zh_cn&edition=full","pubTime":"2026-01-26 11:24","pubTimestamp":1769397840,"startTime":"0","endTime":"0","summary":"2026年1月以来，多家药企宣布延长/深化合作。Syngene International与百时美施贵宝将合作延长至2035年，服务范围扩展至药物研发全生命周期；科伦博泰生物与华润科伦续签2026年研发相关物资框架协议至2028年底，预计将提升产品市场认受性实现收入增长；阿斯利康与药易购召开商务洽谈会，计划在多领域深化协作，聚焦全链路药品追溯等议题，未来将继续共建产业生态；Earendil Labs（华深智药子公司）再次与Sanofi达成战略合作，其药物发现平台将用于多个疾病研发项目，Sanofi将主导双特异性抗体候选药物的研发及全球商业化工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126113919a455b9df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126113919a455b9df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD","03320"],"gpt_icon":0},{"id":"2606296747","title":"科伦博泰生物-B盘中异动 急速跳水3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606296747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606296747?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:36","pubTimestamp":1769391360,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘09时36分，科伦博泰生物-B股票出现波动，股价大幅下挫3.07%。科伦博泰生物-B股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，中生北控生物科技、维亚生物、康希诺生物涨幅较大，振幅较大的相关个股有维亚生物、中生北控生物科技、来凯医药-B，振幅分别为15.35%、13.79%、10.23%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012609360097a35179&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012609360097a35179&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2605927400","title":"科伦博泰生物-B补充披露2026年研发相关物资框架协议定价政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2605927400","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605927400?lang=zh_cn&edition=full","pubTime":"2026-01-23 20:07","pubTimestamp":1769170039,"startTime":"0","endTime":"0","summary":"四川科伦博泰生物医药股份有限公司于2026年1月23日发布补充公告，进一步阐明了2026年研发相关物资框架协议的定价政策。公告指出，在2026年1月1日至16日期间，公司未与华润科伦及其附属公司发生任何交易。公告详细说明了公司拟向华润科伦及其附属公司采购研发相关物资的定价政策，并强调，定价将主要依据研发物资的生产成本、对外第三方的售价以及公司的采购量，通过公平协商确定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123202320a44e74a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123202320a44e74a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":1},{"id":"2605940094","title":"每日卖空追踪 | 科伦博泰生物-B 01月23日卖空量成交6.64万股，卖空比例为9.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605940094","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605940094?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157039,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月23日，涨3.07%，卖空量成交6.64万股，较上一交易日减少1.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164129a44da262&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123164129a44da262&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2605973400","title":"康方生物涨超4%，自研古莫奇单抗第二项适应症获NDA受理，港股通创新药ETF涨近2%，近5日净流入超4.3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605973400","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605973400?lang=zh_cn&edition=full","pubTime":"2026-01-23 11:00","pubTimestamp":1769137200,"startTime":"0","endTime":"0","summary":"1月23日，港股强势反攻，创新药纯度100%的港股通创新药ETF涨近2%，近5日净流入超4.3亿元，规模超251亿元同类领先。消息面上，康方生物自主研发的古莫奇单抗用于治疗活动性强直性脊柱炎的新药上市申请已获受理，有望为近400万患者带来新选择。此外，港股通创新药ETF标的指数权重股多数上涨，康方生物、科伦博泰生物-B涨超4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123111011a44c58e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123111011a44c58e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348783233.USD","LU1720050803.USD","IE00B5MMRT66.SGD","LU0417516738.SGD","LU0417516571.SGD","LU1961090484.USD","LU0417516902.SGD","IE00B543WZ88.USD","09926","BK1574","LU2399975544.HKD","LU1794554557.SGD","LU2488822045.USD","LU2778985437.USD","LU0348827113.USD","LU0348767384.USD","LU0348766576.USD","LU0348784397.USD","BK1161","IE00BPRC5H50.USD","LU0634319403.HKD","LU2476274720.SGD","LU0348825331.USD","LU0540923850.HKD","LU2476274308.USD","LU0348735423.USD","LU0196878994.USD","LU0561508036.HKD","06990"],"gpt_icon":0}],"profile":{"websiteUrl":"http://kelun-biotech.com","stockEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":-0.1068},{"period":"3month","weight":0.0347},{"period":"6month","weight":0.0501},{"period":"1year","weight":1.4448},{"period":"ytd","weight":0.079}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.2713},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"四川科伦博泰生物医药股份有限公司是一家主要从事新药业务的研发、生产和销售的中国公司。该公司主要从事肿瘤学、免疫学及其他治疗领域的创新药物的研发、制造及商业化。该公司的产品为抗体药物偶联物（ADC）SKB264及A166。该公司产品主要用于乳腺癌、非小细胞肺癌、胃肠道癌等非肿瘤疾病的治疗。","exchange":"SEHK","name":"科伦博泰生物-B","nameEN":"SKB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科伦博泰生物-B,06990,科伦博泰生物-B股票,科伦博泰生物-B股票老虎,科伦博泰生物-B股票老虎国际,科伦博泰生物-B行情,科伦博泰生物-B股票行情,科伦博泰生物-B股价,科伦博泰生物-B股市,科伦博泰生物-B股票价格,科伦博泰生物-B股票交易,科伦博泰生物-B股票购买,科伦博泰生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科伦博泰生物-B(06990)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科伦博泰生物-B(06990)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}